• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

糖胺聚糖对C1抑制剂的增强作用:硫酸葡聚糖是血浆中体外补体激活的有效抑制剂。

Potentiation of C1 inhibitor by glycosaminoglycans: dextran sulfate species are effective inhibitors of in vitro complement activation in plasma.

作者信息

Wuillemin W A, te Velthuis H, Lubbers Y T, de Ruig C P, Eldering E, Hack C E

机构信息

Central Laboratory of The Netherlands Red Cross Blood Transfusion Service, University of Amsterdam.

出版信息

J Immunol. 1997 Aug 15;159(4):1953-60.

PMID:9257861
Abstract

Activation of the complement system may contribute to the pathogenesis of many diseases. Hence, an effective inhibitor of complement might be useful to reduce tissue damage. Some glycosaminoglycans (GAG), such as heparin, are known to inhibit the interaction of C1q with activators and the assembly of the classical and the alternative pathway C3 convertases. Furthermore, they may potentiate C1 inhibitor-mediated inactivation of C1s. To search for potential complement inhibitors, we systematically investigated the complement inhibitory properties of various synthetic and naturally occurring GAG (dextran sulfates 500,000 and 5,000, heparin, N-acetylheparin, heparan sulfate, dermatan sulfate, and chondroitin sulfates A and C). First, we assessed the effect of GAG on the second-order rate constant of the inactivation of C1s by C1 inhibitor. This rate constant increased 6- to 130-fold in the presence of the GAG, dextran sulfate being the most effective. Second, all tested GAG were found to reduce deposition of C4 and C3 on immobilized aggregated human IgG (AHG) and to reduce fluid phase formation of C4b/c and C3b/c in recalcified plasma upon incubation with AHG. Dextran sulfate again was found to be most effective. We conclude that GAG modulate complement activation in vitro and that the low molecular weight dextran sulfate (m.w. 5000) may be a candidate for pharmacologic manipulation of complement activation via potentiation of C1 inhibitor.

摘要

补体系统的激活可能在许多疾病的发病机制中起作用。因此,一种有效的补体抑制剂可能有助于减少组织损伤。一些糖胺聚糖(GAG),如肝素,已知可抑制C1q与激活剂的相互作用以及经典途径和替代途径C3转化酶的组装。此外,它们可能增强C1抑制剂介导的C1s失活。为了寻找潜在的补体抑制剂,我们系统地研究了各种合成和天然存在的GAG(硫酸葡聚糖500,000和5,000、肝素、N-乙酰肝素、硫酸乙酰肝素、硫酸皮肤素以及硫酸软骨素A和C)的补体抑制特性。首先,我们评估了GAG对C1抑制剂使C1s失活的二级速率常数的影响。在GAG存在下,该速率常数增加了6至130倍,硫酸葡聚糖最为有效。其次,发现所有测试的GAG都能减少C4和C3在固定化的人聚合IgG(AHG)上的沉积,并减少与AHG孵育后再钙化血浆中C4b/c和C3b/c的液相形成。再次发现硫酸葡聚糖最为有效。我们得出结论,GAG在体外调节补体激活,并且低分子量硫酸葡聚糖(分子量5000)可能是通过增强C1抑制剂对补体激活进行药理调控的候选物。

相似文献

1
Potentiation of C1 inhibitor by glycosaminoglycans: dextran sulfate species are effective inhibitors of in vitro complement activation in plasma.糖胺聚糖对C1抑制剂的增强作用:硫酸葡聚糖是血浆中体外补体激活的有效抑制剂。
J Immunol. 1997 Aug 15;159(4):1953-60.
2
Secreted chondroitin sulfate proteoglycan of human B cell lines binds to the complement protein C1q and inhibits complex formation of C1.人B细胞系分泌的硫酸软骨素蛋白聚糖与补体蛋白C1q结合并抑制C1复合物的形成。
J Immunol. 1997 Feb 1;158(3):1324-31.
3
Influence of low molecular weight heparin and low molecular weight dextran sulfate on the inhibition of coagulation factor XIa by serpins.低分子量肝素和低分子量硫酸葡聚糖对丝氨酸蛋白酶抑制剂抑制凝血因子XIa的影响。
Thromb Haemost. 1998 Jul;80(1):82-6.
4
Glycosaminoglycans enhance complement hemolytic efficiency: theoretical considerations for GAG-complement-saliva interactions.糖胺聚糖增强补体溶血效率:糖胺聚糖-补体-唾液相互作用的理论考量
Mol Immunol. 1986 Aug;23(8):887-93. doi: 10.1016/0161-5890(86)90074-x.
5
Heparin binding and augmentation of C1 inhibitor activity.肝素结合与C1抑制剂活性增强
Arch Biochem Biophys. 1999 Jan 15;361(2):215-22. doi: 10.1006/abbi.1998.0996.
6
The potentiation of human C1-inhibitor by dextran sulphate is transient in vivo: studies in a rat model.硫酸葡聚糖对人C1抑制剂的增强作用在体内是短暂的:大鼠模型研究。
Int Immunopharmacol. 2001 Aug;1(8):1583-95. doi: 10.1016/s1567-5769(01)00073-x.
7
A mechanism for the spontaneous activation of the first component of complement, C1, and its regulation by C1-inhibitor.
J Immunol. 1988 Dec 1;141(11):3930-6.
8
Antibody-independent C1 activation by E. coli.大肠杆菌介导的非抗体依赖性C1激活
J Immunol. 1984 Aug;133(2):886-91.
9
Activator-bound C1 is less susceptible to inactivation by C1 inhibition than is fluid-phase C1.与液相C1相比,与激活剂结合的C1更不易被C1抑制物灭活。
J Immunol. 1986 Jul 15;137(2):625-30.
10
Complexes between C1q and C3 or C4: novel and specific markers for classical complement pathway activation.C1q与C3或C4之间的复合物:经典补体途径激活的新型特异性标志物。
J Immunol Methods. 2005 Mar;298(1-2):35-45. doi: 10.1016/j.jim.2004.12.018.

引用本文的文献

1
Inhibition of chondroitin sulphate-degrading enzyme Chondroitinase ABC by dextran sulphate.硫酸葡聚糖对硫酸软骨素降解酶软骨素酶ABC的抑制作用。
Glycoconj J. 2025 Feb;42(1):53-59. doi: 10.1007/s10719-024-10175-6. Epub 2025 Jan 16.
2
Chemical approaches targeting the hurdles of hepatocyte transplantation: mechanisms, applications, and advances.针对肝细胞移植障碍的化学方法:机制、应用与进展
Front Cell Dev Biol. 2024 Oct 31;12:1480226. doi: 10.3389/fcell.2024.1480226. eCollection 2024.
3
Complement, Coagulation, and Fibrinolysis: The Role of the Endothelium and Its Glycocalyx Layer in Xenotransplantation.
补体、凝血和纤溶:内皮及其糖萼层在异种移植中的作用。
Transpl Int. 2024 Oct 15;37:13473. doi: 10.3389/ti.2024.13473. eCollection 2024.
4
The Inhibition of Serine Proteases by Serpins Is Augmented by Negatively Charged Heparin: A Concise Review of Some Clinically Relevant Interactions.丝氨酸蛋白酶抑制剂通过负电荷肝素增强:一些临床相关相互作用的简要综述。
Int J Mol Sci. 2024 Feb 2;25(3):1804. doi: 10.3390/ijms25031804.
5
Inflammatory stimuli induce shedding of heparan sulfate from arterial but not venous porcine endothelial cells leading to differential proinflammatory and procoagulant responses.炎症刺激诱导动脉而非静脉猪内皮细胞肝素硫酸酯的脱落,导致不同的促炎和促凝血反应。
Sci Rep. 2023 Mar 18;13(1):4483. doi: 10.1038/s41598-023-31396-z.
6
Immune-Protective Formulations and Process Strategies for Improved Survival and Function of Transplanted Islets.免疫保护配方和工艺策略可提高移植胰岛的存活率和功能。
Front Immunol. 2022 Jul 12;13:923241. doi: 10.3389/fimmu.2022.923241. eCollection 2022.
7
The Endothelial Glycocalyx: A Possible Therapeutic Target in Cardiovascular Disorders.内皮糖萼:心血管疾病中一个可能的治疗靶点。
Front Cardiovasc Med. 2022 May 13;9:897087. doi: 10.3389/fcvm.2022.897087. eCollection 2022.
8
Interactions Between Pathogenic and the Complement System: A Review of Potential Immune Evasion Mechanisms.病原体与补体系统的相互作用:潜在免疫逃避机制的综述。
Front Cell Infect Microbiol. 2021 Sep 30;11:701362. doi: 10.3389/fcimb.2021.701362. eCollection 2021.
9
Dextran Sulfate Protects Pancreatic β-Cells, Reduces Autoimmunity, and Ameliorates Type 1 Diabetes.硫酸葡聚糖可保护胰岛β细胞,减少自身免疫,并改善 1 型糖尿病。
Diabetes. 2020 Aug;69(8):1692-1707. doi: 10.2337/db19-0725. Epub 2020 May 7.
10
Regulation of c-Jun NH-Terminal Kinase for Islet Transplantation.c-Jun氨基末端激酶在胰岛移植中的调控
J Clin Med. 2019 Oct 23;8(11):1763. doi: 10.3390/jcm8111763.